What Is Treatment-Resistant Depression?
Treatment-resistant depression (TRD) is generally defined as major depressive disorder that has not responded adequately to at least two different antidepressant medications, each taken at an appropriate dose for a sufficient duration (typically 6–8 weeks). By some estimates, roughly one-third of people with depression meet this criteria.
TRD is not a reflection of personal failure. It is a neurological reality: some brains simply do not respond to serotonin- and norepinephrine-based medications. This is precisely where ketamine therapy becomes relevant, because it works through an entirely different mechanism.
Why Ketamine Works for TRD
Unlike traditional antidepressants that target serotonin or norepinephrine, ketamine acts on the glutamate system — specifically the NMDA receptor. This triggers a cascade of neuroplasticity-related changes that can produce rapid mood improvements, sometimes within hours rather than weeks.
Key advantages of ketamine for TRD patients:
- Different mechanism of action: Works even when SSRIs, SNRIs, and tricyclics have failed
- Rapid onset: Many patients notice improvement within 24–72 hours of their first treatment
- Neuroplasticity effects: Ketamine promotes synaptic growth and connectivity, potentially addressing the structural brain changes associated with chronic depression
- Well-studied: Decades of clinical research support ketamine's efficacy for TRD, including FDA approval of the related compound esketamine (Spravato)
For a broader overview of how ketamine treats depression, see Ketamine for Depression Guide.
Why Dose Flexibility Is Critical for TRD
This is the most important consideration for TRD patients choosing an at-home provider, and it is where most services fall short.
Treatment-resistant depression, by definition, means standard approaches have not worked. TRD patients often need:
- Higher initial doses to reach a therapeutic threshold
- Dose adjustments over time as the brain responds and adapts
- Flexibility to increase if a starting dose proves insufficient
- Ongoing access rather than limited program durations
Providers that impose strict dose caps effectively tell TRD patients: "If our standard dose does not work for you, that is not our problem." For a population that has already failed on multiple medications, this is exactly the wrong approach.
Best Provider for TRD: Kalm Health
Kalm Health Best for TRD
$124/month · No dose cap · Higher-dose plan available
Kalm Health is our top recommendation for TRD patients for one overriding reason: no dose cap. Their prescribers can adjust dosing based on clinical response without being constrained by a business-model-driven limit on how much medication a patient receives.
For TRD patients who need more intensive treatment, the higher-dose plan at $174 every two months provides a structured option that remains remarkably affordable. At an effective cost of $87 per month, it is cheaper than most competitors' standard plans.
The $0 consultation fee also matters for TRD patients, who may have already spent significant money on treatments that did not work. There is no financial risk to starting the conversation.
- No dose cap — clinician adjusts based on your response
- Higher-dose plan at $174/2 months for intensive treatment
- $0 initial consultation
- $124/month base plan — the lowest in the market
- Ongoing treatment without program expiration
How Other Providers Handle TRD
| Provider | Dose Flexibility | TRD Suitability | Notes |
|---|---|---|---|
| Kalm Health | No cap | Excellent | Clinician-driven dosing, higher-dose plan available |
| Joyous | Low, capped | Limited | Fixed low-dose protocol may be sub-therapeutic for TRD |
| Mindbloom | Per-session | Good | Higher doses possible but at high per-session cost |
| Better U | Moderate | Moderate | Some flexibility but coaching focus may not address TRD needs |
| Nue Life | Standardized | Moderate | Protocol-driven, limited individualization |
| Peak | Limited | Moderate | Standard telehealth model with some adjustment |
| Isha Health | Moderate | Good | Integration focus helps TRD but cost is high |
What TRD Patients Should Ask Before Choosing a Provider
If you have treatment-resistant depression, ask these specific questions during your initial consultation:
- "Is there a maximum dose you will prescribe?" — If yes, find out what it is and whether it aligns with clinical guidelines for TRD dosing.
- "How do you handle patients who don't respond to the starting dose?" — The answer should involve clinical evaluation and dose adjustment, not "try it longer" or "this may not be for you."
- "What is my path to a higher dose if I need one?" — With Kalm, the answer is straightforward: your clinician adjusts your protocol or you move to the higher-dose plan.
- "Are there additional fees for dose changes?" — Some providers charge for follow-up consultations to adjust dosing.
- "Is treatment ongoing or program-based?" — TRD often requires sustained treatment. Providers with fixed program durations may leave you without access when you still need it.
Combining Ketamine with Other Treatments for TRD
At-home ketamine therapy is often most effective when combined with other interventions:
- Psychotherapy: Particularly CBT or psychodynamic therapy during the neuroplasticity window that ketamine opens
- Exercise: Regular physical activity amplifies ketamine's antidepressant effects through complementary neurochemical pathways
- Sleep optimization: Addressing sleep disruption can improve ketamine response rates
- Existing medications: Ketamine is generally safe alongside most antidepressants, though this should be managed by your prescriber
Always discuss your full treatment plan with your prescribing clinician. For more on managing at-home ketamine treatment, see At-Home Ketamine Guide.